| KR | 8-K | neutral | 5/10 | Kroger held an investor update introducing new long-term financial targets: approximately 3% comparable sales growth (ex | Oct 20, 2026 |
| HAL | 8-K | bearish | 6/10 | Halliburton reported Q3 2026 adjusted EPS of $0.60, a 6.3% sequential decline from Q2's $0.64, on flat revenue of $5.7B. | Oct 20, 2026 |
| AUB | 8-K | neutral | 4/10 | Atlantic Union Bankshares reported Q3 2026 GAAP diluted EPS of $0.94, slightly below the $0.98 consensus estimate, while | Oct 20, 2026 |
| MSCI | 8-K | neutral | 4/10 | MSCI reported Q3 2026 results with operating revenues of $892.0M (+12.4% YoY) and diluted GAAP EPS of $4.86 (+14.4% YoY) | Oct 20, 2026 |
| MMM | 8-K | bullish | 7/10 | 3M reported Q3 2026 adjusted EPS of $2.50, a 22.9% beat vs the $2.03 consensus, on adjusted sales of $6.6B (+4.2% YoY). | Oct 20, 2026 |
| QNRX | 8-K | bullish | 6/10 | Quoin Pharmaceuticals announced the publication of a peer-reviewed paper in Dermatology and Therapy detailing a pediatri | Oct 20, 2026 |
| HAS | 8-K | bullish | 7/10 | Hasbro reported Q3 2026 adjusted EPS of $2.90, a 93.2% beat vs. the $1.50 consensus, on revenue of $1.595B (11.5% above | Oct 20, 2026 |
| EFX | 8-K | mixed | 6/10 | Equifax reported Q3 2026 revenue of $1.6925B (+10% YoY) and adjusted EPS of $2.26 (+11% YoY), beating consensus estimate | Oct 20, 2026 |
| GE | 8-K | bullish | 7/10 | GE Aerospace reported Q3 2026 adjusted EPS of $2.25, a 36% YoY increase, on adjusted revenue of $13.3B (+18% YoY). The c | Oct 20, 2026 |
| KEY | 8-K | bullish | 6/10 | KeyCorp reported Q3 2026 EPS of $0.51, a 1.9% beat vs consensus of $0.50, on record revenue of $2.04B (+8% YoY). Net int | Oct 20, 2026 |
| BNAI | 8-K | neutral | 3/10 | Brand Engagement Network provided an update on cost reduction actions related to its June 30, 2026 acquisition of Catane | Oct 20, 2026 |
| DCOM | 8-K | mixed | 6/10 | Dime Commercial Bancshares reported Q3 2026 GAAP diluted EPS of $0.90 (adjusted $0.91), a 53% YoY increase, on record qu | Oct 20, 2026 |
| PEBO | 8-K | neutral | 5/10 | Peoples Bancorp reported Q3 2026 GAAP diluted EPS of $0.91, a 9.6% YoY increase from $0.83, but a 2.3% miss vs the $0.93 | Oct 20, 2026 |
| RAPP | 8-K | bullish | 7/10 | Rapport Therapeutics announced positive topline Phase 2 results for RAP-219 in acute bipolar mania, meeting the primary | Oct 20, 2026 |
| KMB | 8-K | neutral | 4/10 | Kimberly-Clark priced a $4.9 billion private offering of senior unsecured notes across five tranches to fund the cash co | Oct 20, 2026 |
| SYF | 8-K | neutral | 3/10 | Synchrony Financial furnished its monthly charge-off and delinquency statistics for the thirteen months ended September | Oct 20, 2026 |
| AITX | 8-K | neutral | 4/10 | AITX issued a press release projecting monthly operating cash breakeven in January 2027 and all-in cash breakeven in Q2 | Oct 20, 2026 |
| SYF | 8-K | bearish | 6/10 | Synchrony Financial reported Q3 2026 net earnings of $892M ($2.68 diluted EPS), down 17% YoY from $1.077B ($2.86), as re | Oct 20, 2026 |
| NOC | 8-K | bullish | 6/10 | Northrop Grumman reported Q3 2026 sales of $11.1B (+7% YoY) and diluted EPS of $7.89, slightly below the consensus estim | Oct 20, 2026 |
| BCAB | 8-K | bearish | 6/10 | BioAtla entered into a new Standby Equity Purchase Agreement (SEPA) with Yorkville for up to $40M in common stock, repla | Oct 19, 2026 |
| SLGN | 8-K | mixed | 7/10 | Silgan Holdings (SLGN) entered into a definitive Transaction Agreement to spin off its metal packaging business into a n | Oct 19, 2026 |
| FOXA | 8-K | neutral | 3/10 | Fox Corp announced that Chief Legal & Policy Officer Adam Ciongoli will step down effective December 1, 2026, and transi | Oct 19, 2026 |
| ANVS | 8-K | neutral | 1/10 | Annovis Bio filed an 8-K to correct a typographical error in its June 17, 2026 proxy statement regarding audit fees. The | Oct 19, 2026 |
| NWSA | 8-K | neutral | 2/10 | News Corp filed an 8-K to disclose daily buy-back notifications provided to the Australian Securities Exchange (ASX) und | Oct 19, 2026 |
| CLNN | 8-K | neutral | 3/10 | Clene Inc. entered into a subaward amendment with NYU Grossman School of Medicine for the fourth year of its NIH grant, | Oct 19, 2026 |
| TVA | 8-K | bearish | 7/10 | Texas Ventures Acquisition III Corp (TVA) held an extraordinary general meeting on October 19, 2026, where shareholders | Oct 19, 2026 |
| GBFH | 8-K | neutral | 2/10 | GBank Financial Holdings Inc. filed an 8-K on October 19, 2026, solely to announce the scheduled release of its Q3 2026 | Oct 19, 2026 |
| INV | 8-K | neutral | 3/10 | Innventure, Inc. announced the departure of CFO David Yablunosky, the appointment of Eric Stober as the new CFO, and the | Oct 19, 2026 |
| CHRD | 8-K | mixed | 6/10 | Chord Energy reported preliminary Q3 2026 operational results with oil volumes exceeding the high-end of guidance and Ca | Oct 19, 2026 |
| PHUN | 8-K | neutral | 4/10 | Phunware filed an 8-K to post an updated investor presentation and announce its CEO's presentation at the LD Micro 20th | Oct 19, 2026 |